Acid-Activated Structural Reorganization of the Rift Valley Fever Virus Gc Fusion Protein

被引:59
作者
de Boer, S. M. [1 ,2 ]
Kortekaas, J. [2 ]
Spel, L. [1 ]
Rottier, P. J. M. [1 ]
Moormann, R. J. M. [1 ,2 ]
Bosch, B. J. [1 ]
机构
[1] Univ Utrecht, Fac Vet Med, Div Virol, Dept Immunol & Infect Dis, Utrecht, Netherlands
[2] Univ Wageningen & Res Ctr, Dept Virol, Cent Vet Inst, Lelystad, Netherlands
关键词
SEMLIKI-FOREST-VIRUS; CONSERVED HISTIDINE-RESIDUES; MEMBRANE-FUSION; CELL-FUSION; HEMORRHAGIC-FEVER; GLYCOPROTEIN; PH; ENTRY; CLATHRIN; INFLUENZA;
D O I
10.1128/JVI.01973-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The entry of the enveloped Rift Valley fever virus (RVFV) into its host cell is mediated by the viral glycoproteins Gn and Gc. We investigated the RVFV entry process and, in particular, its pH-dependent activation mechanism using our recently developed nonspreading-RVFV-particle system. Entry of the virus into the host cell was efficiently inhibited by lysosomotropic agents that prevent endosomal acidification and by compounds that interfere with dynamin-and clathrin-dependent endocytosis. Exposure of plasma membrane-bound virions to an acidic pH (<pH 6) equivalent to the pH of late endolysosomal compartments allowed the virus to bypass the endosomal route of infection. Acid exposure of virions in the absence of target membranes triggered the class II-like Gc fusion protein to form extremely stable oligomers that were resistant to SDS and temperature dissociation and concomitantly compromised virus infectivity. By targeted mutagenesis of conserved histidines in Gn and Gc, we demonstrated that mutation of a single histidine (H857) in Gc completely abrogated virus entry, as well as acid-induced Gc oligomerization. In conclusion, our data suggest that after endocytic uptake, RVFV traffics to the acidic late endolysosomal compartments, where histidine protonation drives the reorganization of the Gc fusion protein that leads to membrane fusion.
引用
收藏
页码:13642 / 13652
页数:11
相关论文
共 69 条
[1]   CELL-FUSION BY HEMORRHAGIC-FEVER WITH RENAL SYNDROME (HFRS) VIRUSES AND ITS APPLICATION FOR TITRATION OF VIRUS INFECTIVITY AND NEUTRALIZING ANTIBODY [J].
ARIKAWA, J ;
TAKASHIMA, I ;
HASHIMOTO, N .
ARCHIVES OF VIROLOGY, 1985, 86 (3-4) :303-313
[2]   Rift Valley fever: an uninvited zoonosis in the Arabian peninsula [J].
Balkhy, HH ;
Memish, ZA .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (02) :153-157
[3]   Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2 [J].
Boo, Irene ;
teWierik, Kevin ;
Douam, Florian ;
Lavillette, Dimitri ;
Poumbourios, Pantelis ;
Drummer, Heidi E. .
BIOCHEMICAL JOURNAL, 2012, 443 :85-94
[4]   Membrane fusion induced by vesicular stomatitis virus depends on histidine protonation [J].
Carneiro, FA ;
Stauffer, F ;
Lima, CS ;
Juliano, MA ;
Juliano, L ;
Da Poian, AT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) :13789-13794
[5]   Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection [J].
Chandran, K ;
Sullivan, NJ ;
Felbor, U ;
Whelan, SP ;
Cunningham, JM .
SCIENCE, 2005, 308 (5728) :1643-1645
[6]   Second-site revertants of a Semliki Forest virus fusion-block mutation reveal the dynamics of a class II membrane fusion protein [J].
Chanel-Vos, Chantal ;
Kielian, Margaret .
JOURNAL OF VIROLOGY, 2006, 80 (12) :6115-6122
[7]   SITE-DIRECTED MUTAGENESIS AND CHEMICAL MODIFICATION OF HISTIDINE-RESIDUES ON AN ALPHA-CLASS CHICK LIVER GLUTATHIONE-S-TRANSFERASE CL 3-3 - HISTIDINES ARE NOT NEEDED FOR THE ACTIVITY OF THE ENZYME AND DIETHYLPYROCARBONATE MODIFIES BOTH HISTIDINE AND LYSINE RESIDUES [J].
CHANG, LH ;
TAM, MF .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 211 (03) :805-811
[8]   Cell Entry of Enveloped Viruses [J].
Cosset, Francois-Loic ;
Lavillette, Dimitri .
ADVANCES IN GENETICS, VOL 73, 2011, 73 :121-183
[9]   Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge [J].
de Boer, S. M. ;
Kortekaas, J. ;
Antonis, A. F. ;
Kant, J. ;
van Oploo, J. L. ;
Rottier, P. J. M. ;
Moormann, R. J. M. ;
Bosch, B. J. .
VACCINE, 2010, 28 (11) :2330-2339
[10]  
Fass D, 2003, ADV PROTEIN CHEM, V64, P325